---
figid: PMC3001953__oncotarget-01-497-g002
figlink: /pmc/articles/PMC3001953/figure/F2/
number: Figure 2
caption: EGFR dimerization results in autophosphorylation, kinase activation, and
  subsequent activation of three major signaling pathways,including RAS/RAF/MEK/ERK1/2,
  PI3K/AKT and STATs pathways. BIM is significantly induced to exhibit pro-apoptotic
  functions upon EGFR inhibition via mostly ERK regulation in NSCLC cells. Cyclin
  D1 is greatly suppressed by EGFR inhibition, promoting cell cycle arrest. ERK1/2
  signalling is typically negatively regulated by a family of dual-specific MAPK phosphatases,
  known as DUSPs or MKPs, especially DUSP1, DUSP4, and DUSP6 in NSCLC. DUSP1 and DUSP4
  function to terminate ERK signaling in nucleus whereas DUSP6 inhibits ERK activation
  in the cytoplasm.
pmcid: PMC3001953
papertitle: 'EGFR-mutated lung cancer: a paradigm of molecular oncology.'
reftext: Zhenfeng Zhang, et al. Oncotarget. 2010 Nov;1(7):497-514.
pmc_ranked_result_index: '680'
pathway_score: 0.9534289
filename: oncotarget-01-497-g002.jpg
figtitle: 'EGFR-mutated lung cancer: a paradigm of molecular oncology'
year: '2010'
organisms: Homo sapiens
ndex: f433aeeb-deeb-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3001953__oncotarget-01-497-g002.html
  '@type': Dataset
  description: EGFR dimerization results in autophosphorylation, kinase activation,
    and subsequent activation of three major signaling pathways,including RAS/RAF/MEK/ERK1/2,
    PI3K/AKT and STATs pathways. BIM is significantly induced to exhibit pro-apoptotic
    functions upon EGFR inhibition via mostly ERK regulation in NSCLC cells. Cyclin
    D1 is greatly suppressed by EGFR inhibition, promoting cell cycle arrest. ERK1/2
    signalling is typically negatively regulated by a family of dual-specific MAPK
    phosphatases, known as DUSPs or MKPs, especially DUSP1, DUSP4, and DUSP6 in NSCLC.
    DUSP1 and DUSP4 function to terminate ERK signaling in nucleus whereas DUSP6 inhibits
    ERK activation in the cytoplasm.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - MAP2K1
  - SOS1
  - HRAS
  - MAP2K2
  - KRAS
  - BRAF
  - ARAF
  - DUSP8
  - NRAS
  - GRB2
  - ETS1
  - DUSP4
  - MAPK1
  - PIK3R6
  - PIK3CG
  - PIK3CD
  - DUSP6
  - MAPK3
  - RAF1
  - DUSP1
  - AKT2
  - PIK3R3
  - PIK3CA
  - SOS2
  - AKT1
  - AKT3
  - PIK3R5
  - PIK3R4
  - CCND1
  - BCL2L11
  - PIK3CB
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: DUSP8
  symbol: DUSP8
  source: hgnc_symbol
  hgnc_symbol: DUSP8
  entrez: '1850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Grb-2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: ETS-1
  symbol: ETS-1
  source: hgnc_alias_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: DUSP1/4
  symbol: DUSP4
  source: hgnc_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: DUSP6
  symbol: DUSP6
  source: hgnc_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: DUSP1/4
  symbol: DUSP1
  source: hgnc_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: BIM
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: CCND1
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
